Literature DB >> 28885017

Parameterization of Acyclic Diaminocarbene Ligands Applied to a Gold(I)-Catalyzed Enantioselective Tandem Rearrangement/Cyclization.

Zachary L Niemeyer1, Suresh Pindi2, Dimitri A Khrakovsky2, Christian N Kuzniewski2, Cynthia M Hong2, Leo A Joyce3, Matthew S Sigman1, F Dean Toste2.   

Abstract

Computed descriptors for acyclic diaminocarbene ligands are developed in the context of a gold catalyzed enantioselective tandem [3,3]-sigmatropic rearrangement-[2+2]-cyclization. Surrogate structures enable the rapid identification of parameters that reveal mechanistic characteristics. The observed selectivity trends are validated in a robust multivariate analysis facilitating the development of a highly enantioselective process.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28885017      PMCID: PMC5903265          DOI: 10.1021/jacs.7b08791

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  31 in total

1.  Ligand effects and ligand design in homogeneous gold(I) catalysis.

Authors:  Weibo Wang; Gerald B Hammond; Bo Xu
Journal:  J Am Chem Soc       Date:  2012-03-16       Impact factor: 15.419

2.  Gold(I)-catalyzed stereoselective olefin cyclopropanation.

Authors:  Magnus J Johansson; David J Gorin; Steven T Staben; F Dean Toste
Journal:  J Am Chem Soc       Date:  2005-12-28       Impact factor: 15.419

3.  Enantioselective gold catalysis: opportunities provided by monodentate phosphoramidite ligands with an acyclic TADDOL backbone.

Authors:  Henrik Teller; Susanne Flügge; Richard Goddard; Alois Fürstner
Journal:  Angew Chem Int Ed Engl       Date:  2010-03-08       Impact factor: 15.336

Review 4.  Gold-Catalyzed Enantioselective Annulations.

Authors:  Yangyan Li; Wenbo Li; Junliang Zhang
Journal:  Chemistry       Date:  2016-10-10       Impact factor: 5.236

5.  NBO 6.0: natural bond orbital analysis program.

Authors:  Eric D Glendening; Clark R Landis; Frank Weinhold
Journal:  J Comput Chem       Date:  2013-03-09       Impact factor: 3.376

6.  Axially chiral triazoloisoquinolin-3-ylidene ligands in gold(I)-catalyzed asymmetric intermolecular (4 + 2) cycloadditions of allenamides and dienes.

Authors:  Javier Francos; Francisca Grande-Carmona; Hélio Faustino; Javier Iglesias-Sigüenza; Elena Díez; Isaac Alonso; Rosario Fernández; José M Lassaletta; Fernando López; José L Mascareñas
Journal:  J Am Chem Soc       Date:  2012-08-23       Impact factor: 15.419

7.  Phosphoramidite gold(I)-catalyzed diastereo- and enantioselective synthesis of 3,4-substituted pyrrolidines.

Authors:  Ana Z González; Diego Benitez; Ekaterina Tkatchouk; William A Goddard; F Dean Toste
Journal:  J Am Chem Soc       Date:  2011-03-23       Impact factor: 15.419

8.  Enantioselective alkynylbenzaldehyde cyclizations catalyzed by chiral gold(I) acyclic diaminocarbene complexes containing weak Au-arene interactions.

Authors:  Sachin Handa; LeGrande M Slaughter
Journal:  Angew Chem Int Ed Engl       Date:  2012-01-04       Impact factor: 15.336

Review 9.  Ligand effects in homogeneous Au catalysis.

Authors:  David J Gorin; Benjamin D Sherry; F Dean Toste
Journal:  Chem Rev       Date:  2008-07-25       Impact factor: 60.622

10.  Gold(I)-Catalyzed Activation of Alkynes for the Construction of Molecular Complexity.

Authors:  Ruth Dorel; Antonio M Echavarren
Journal:  Chem Rev       Date:  2015-04-06       Impact factor: 60.622

View more
  11 in total

1.  A Physical Organic Approach to Tuning Reagents for Selective and Stable Methionine Bioconjugation.

Authors:  Alec H Christian; Shang Jia; Wendy Cao; Patricia Zhang; Arismel Tena Meza; Matthew S Sigman; Christopher J Chang; F Dean Toste
Journal:  J Am Chem Soc       Date:  2019-07-30       Impact factor: 15.419

2.  Mechanistically Guided Predictive Models for Ligand and Initiator Effects in Copper-Catalyzed Atom Transfer Radical Polymerization (Cu-ATRP).

Authors:  Cheng Fang; Marco Fantin; Xiangcheng Pan; Kurt de Fiebre; Michelle L Coote; Krzysztof Matyjaszewski; Peng Liu
Journal:  J Am Chem Soc       Date:  2019-04-29       Impact factor: 15.419

3.  Diastereo- and Enantioselective CuH-Catalyzed Hydroamination of Strained Trisubstituted Alkenes.

Authors:  Sheng Feng; Hua Hao; Peng Liu; Stephen L Buchwald
Journal:  ACS Catal       Date:  2019-11-21       Impact factor: 13.084

Review 4.  Quantitative Structure-Selectivity Relationships in Enantioselective Catalysis: Past, Present, and Future.

Authors:  Andrew F Zahrt; Soumitra V Athavale; Scott E Denmark
Journal:  Chem Rev       Date:  2019-12-30       Impact factor: 60.622

5.  From Thioureas to Thioquinolines through Isolated Benzothiazines by Gold Catalysis.

Authors:  Daniel Salvador; M Concepción Gimeno
Journal:  Chemistry       Date:  2021-12-04       Impact factor: 5.020

6.  Kinetic resolution of indolines by asymmetric hydroxylamine formation.

Authors:  Gang Wang; Ran Lu; Chuangchuang He; Lei Liu
Journal:  Nat Commun       Date:  2021-05-04       Impact factor: 14.919

7.  Highly Efficient Cyclization Approach of Propargylated Peptides via Gold(I)-Mediated Sequential C-N, C-O, and C-C Bond Formation.

Authors:  Rajeshwer Vanjari; Emad Eid; Ganga B Vamisetti; Shaswati Mandal; Ashraf Brik
Journal:  ACS Cent Sci       Date:  2021-11-18       Impact factor: 14.553

8.  Access to substituted cyclobutenes by tandem [3,3]-sigmatropic rearrangement/[2 + 2] cycloaddition of dipropargylphosphonates under Ag/Co relay catalysis.

Authors:  Qijian Ni; Xiaoxiao Song; Chin Wen Png; Yongliang Zhang; Yu Zhao
Journal:  Chem Sci       Date:  2020-10-16       Impact factor: 9.825

9.  Asymmetric construction of pyrido[1,2-a]-1H-indole derivatives via a gold-catalyzed cycloisomerization.

Authors:  Feng Jiang; Chunling Fu; Shengming Ma
Journal:  Chem Sci       Date:  2020-10-22       Impact factor: 9.825

Review 10.  New-Generation Ligand Design for the Gold-Catalyzed Asymmetric Activation of Alkynes.

Authors:  Giuseppe Zuccarello; Imma Escofet; Ulysse Caniparoli; Antonio M Echavarren
Journal:  Chempluschem       Date:  2021-09       Impact factor: 2.863

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.